Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quanex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Quanex between December 12, 2024 and September 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Faruq ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Faruqi & F ...

公司法律诉讼 - 律师事务所Faruqi & Faruqi正在调查针对VFC公司的潜在索赔 并提醒投资者在2025年11月12日前申请成为集体诉讼的首席原告 [3] - 诉讼指控公司及其高管在2023年10月30日至2025年5月20日期间 通过发布虚假和/或误导性陈述及/或未能披露信息 违反了联邦证券法 [1][5] - 指控涉及公司转型计划的真实状况 特别是需要采取额外的重大重置行动才能使Vans品牌恢复增长 这导致Vans的收入增长轨迹遭受重大挫折 [5] 公司业绩披露与市场反应 - 2025年5月21日 VFC公司公布了2025财年第四季度及全年业绩 披露Vans品牌增长轨迹显著恶化 [6] - Vans品牌的收入下滑从上一季度的8%恶化至第四季度的20% 并且公司预计这种下滑将持续到下一季度 [6] - 公司将业绩及低于预期的指引归因于"为淘汰无利可图或无效业务而刻意减少收入的直接效应"以及一套先前未公布的"额外的一系列刻意行动" [6] - 业绩公布后 公司股价从2025年5月20日的每股14.43美元收盘价 下跌至2025年5月21日的每股12.15美元 单日跌幅约为15.8% [6]

SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. The new class action, King v. aTyr Pharma Inc., filed in the U.S. District Court for the Southern District of California on behalf of investors who suffered substantial losses, now seeks to represent all persons and entities who acquired aTyr Pharm ...

Accessibility StatementSkip Navigation On this news, Jasper's stock price fell $3.73 per share, or 55.1%, to close at $3.04 per share on July 7, 2025. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may cho ...

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Quanex To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP also encourages anyone with information regarding Quanex's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. If you suffered losses exceeding $75,000 in Quanex between December 12, 2024 and September 5, 2025 and wou ...

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212- 983-9330Â (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In James Hardie To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in James Hardie between May 20, 2025 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- ...

[You may also click here for additional information] NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) and reminds investors of the November 17, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi ...

公司业绩与股价表现 - 2025年7月9日WPP发布2025年上半年交易更新，披露其业绩在第二季度出现恶化[3] - 公司将业绩不佳归因于持续的宏观不确定性抑制客户支出，以及净新业务增长弱于最初预期，部分原因是WPP Media（即GroupM）持续重组对业务造成了一些干扰[3] - 2025年7月8日WPP普通股收盘价为每股35.82美元，在2025年7月9日股价下跌至每股29.34美元，单日跌幅约18.1%[4] 公司声明与指控 - 诉讼指控公司及其高管通过就2025财年预期收入做出虚假和/或误导性陈述，未能披露重大信息，违反了联邦证券法[2] - 被告声明包括对公司重振和简化媒体部门以获取新客户和保留客户群的努力充满信心，并反复声称“新业务增长”和向现有客户的持续销售将抵消客户流失，同时持续强调公司自称已考虑“广泛宏观不确定性”的“谨慎”指引[2] - 据称，公司在向投资者提供这些极为积极的陈述时，同时传播了 materially false and misleading statements 和/或隐瞒了有关WPP媒体部门真实状况的重大不利事实，特别是其并未真正准备好应对持续的宏观经济挑战并在竞争中保持有效，反而开始丧失大量市场份额给竞争对手[2]